
There’s early promise in the quest for a blood test that might spot breast cancer up to five years before clinical signs of the disease appear, researchers say. The test identifies specific immune system “autoantibodies,” British researchers explained. The immune system produces the antibodies when it comes into contact with tumor-associated antigens (TAAs), which are… read on >